Cargando…

Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria

This study investigated the genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-Sp) in Osogbo, southwest Nigeria. Blood sample was obtained from consenting pregnant women attending antenatal clinics. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Olowe, Rita A, Ojo, Johnson A, Funwei, Roland I, Oyedeji, Segun I, Olowe, Olugbenga A, Thomas, Bolaji N, Ojurongbe, Olusola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Makerere Medical School 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398500/
https://www.ncbi.nlm.nih.gov/pubmed/37545953
http://dx.doi.org/10.4314/ahs.v23i1.80
_version_ 1785084073979412480
author Olowe, Rita A
Ojo, Johnson A
Funwei, Roland I
Oyedeji, Segun I
Olowe, Olugbenga A
Thomas, Bolaji N
Ojurongbe, Olusola
author_facet Olowe, Rita A
Ojo, Johnson A
Funwei, Roland I
Oyedeji, Segun I
Olowe, Olugbenga A
Thomas, Bolaji N
Ojurongbe, Olusola
author_sort Olowe, Rita A
collection PubMed
description This study investigated the genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-Sp) in Osogbo, southwest Nigeria. Blood sample was obtained from consenting pregnant women attending antenatal clinics. Microscopy and Polymerase chain reaction (PCR) were employed to diagnose and analyse genetic diversity. Of the 301 samples, 53 (18%) and 83 (28%) were positive for P. falciparum by microscopy and PCR, respectively. Using the merozoite surface protein (msp)-1, msp-2, and glutamate-rich protein (glurp) genes of P. falciparum as polymorphic markers, the msp-1 gene showed nine alleles with R033 (66.7%) being predominant, followed by K1 (45.5%) and MAD20 (33.3%). The msp-2 gene had 16 alleles (eight each for FC27 and 3D7). The 3D7 alleles (82.1%) was significantly more than FC27 alleles (48.2%) (p = 0.0093). Nine alleles were detected with glurp gene, presenting with the highest monoclonal and the lowest polyclonal infection. The multiplicity of infection (MOI) of 1.5, 1.8, and 1.2 were obtained for msp-1, msp-2 and glurp genes. In light of the high P. falciparum genetic diversity among pregnant women on IPT-Sp in this study, additional strategies for preventing and controlling malaria in pregnancy might be required.
format Online
Article
Text
id pubmed-10398500
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Makerere Medical School
record_format MEDLINE/PubMed
spelling pubmed-103985002023-08-04 Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria Olowe, Rita A Ojo, Johnson A Funwei, Roland I Oyedeji, Segun I Olowe, Olugbenga A Thomas, Bolaji N Ojurongbe, Olusola Afr Health Sci Articles This study investigated the genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-Sp) in Osogbo, southwest Nigeria. Blood sample was obtained from consenting pregnant women attending antenatal clinics. Microscopy and Polymerase chain reaction (PCR) were employed to diagnose and analyse genetic diversity. Of the 301 samples, 53 (18%) and 83 (28%) were positive for P. falciparum by microscopy and PCR, respectively. Using the merozoite surface protein (msp)-1, msp-2, and glutamate-rich protein (glurp) genes of P. falciparum as polymorphic markers, the msp-1 gene showed nine alleles with R033 (66.7%) being predominant, followed by K1 (45.5%) and MAD20 (33.3%). The msp-2 gene had 16 alleles (eight each for FC27 and 3D7). The 3D7 alleles (82.1%) was significantly more than FC27 alleles (48.2%) (p = 0.0093). Nine alleles were detected with glurp gene, presenting with the highest monoclonal and the lowest polyclonal infection. The multiplicity of infection (MOI) of 1.5, 1.8, and 1.2 were obtained for msp-1, msp-2 and glurp genes. In light of the high P. falciparum genetic diversity among pregnant women on IPT-Sp in this study, additional strategies for preventing and controlling malaria in pregnancy might be required. Makerere Medical School 2023-03 /pmc/articles/PMC10398500/ /pubmed/37545953 http://dx.doi.org/10.4314/ahs.v23i1.80 Text en © 2023 Olowe RA et al. https://creativecommons.org/licenses/by/4.0/Licensee African Health Sciences. This is an Open Access article distributed under the terms of the Creative commons Attribution License (https://creativecommons.org/licenses/BY/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Olowe, Rita A
Ojo, Johnson A
Funwei, Roland I
Oyedeji, Segun I
Olowe, Olugbenga A
Thomas, Bolaji N
Ojurongbe, Olusola
Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria
title Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria
title_full Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria
title_fullStr Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria
title_full_unstemmed Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria
title_short Genetic diversity of Plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria
title_sort genetic diversity of plasmodium falciparum among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in nigeria
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398500/
https://www.ncbi.nlm.nih.gov/pubmed/37545953
http://dx.doi.org/10.4314/ahs.v23i1.80
work_keys_str_mv AT oloweritaa geneticdiversityofplasmodiumfalciparumamongasymptomaticpregnantwomenonintermittentpreventivetreatmentwithsulfadoxinepyrimethamineinnigeria
AT ojojohnsona geneticdiversityofplasmodiumfalciparumamongasymptomaticpregnantwomenonintermittentpreventivetreatmentwithsulfadoxinepyrimethamineinnigeria
AT funweirolandi geneticdiversityofplasmodiumfalciparumamongasymptomaticpregnantwomenonintermittentpreventivetreatmentwithsulfadoxinepyrimethamineinnigeria
AT oyedejiseguni geneticdiversityofplasmodiumfalciparumamongasymptomaticpregnantwomenonintermittentpreventivetreatmentwithsulfadoxinepyrimethamineinnigeria
AT oloweolugbengaa geneticdiversityofplasmodiumfalciparumamongasymptomaticpregnantwomenonintermittentpreventivetreatmentwithsulfadoxinepyrimethamineinnigeria
AT thomasbolajin geneticdiversityofplasmodiumfalciparumamongasymptomaticpregnantwomenonintermittentpreventivetreatmentwithsulfadoxinepyrimethamineinnigeria
AT ojurongbeolusola geneticdiversityofplasmodiumfalciparumamongasymptomaticpregnantwomenonintermittentpreventivetreatmentwithsulfadoxinepyrimethamineinnigeria